The Jaklenec Research Group at the MIT Koch Institute for Integrative Cancer Research, works at the interface of engineering and immunology with a focus on global health. The lab develops innovative and translatable technologies to help large populations globally and especially in developing countries.
The Jaklenec Group
Engineering delivery systems for global health
-
Microparticles to control the pulsatile release of biologics
Medical information storage under the skin
Microparticles to help fight malnutrition
Probiotic and antibiotics combined to eradicate drug-resistant bacteria
A predictive framework for microparticle-based drug injectability
